Capex Announcement
Updates dailyCapacity Surge, Margin Recovery Ahead Subam Papers' 71% capacity expansion targets high-margin 80-120 GSM segment, driving 40-50% revenue potential. Near-term margin pressure (-100-200 bps in 2025) from depreciation normalizes post-COGEN (June 2026), unlocking ₹30-50 Cr annual energy savings. EBITDA margins expand to 24-27% by 2027, supported by operating leverage and premium pricing. Critical success factors: utilization ramp-up (60-70% Year 1) and COGEN timeline adherence. Long-term fundamentals strengthen substantially; near-term execution risk requires monitoring.
Capacity Surge, Margin Recovery Ahead Subam Papers' 71% capacity expansion targets high-margin 80-120 GSM segment, driving 40-50% revenue potential. Near-term margin pressure (-100-200 bps in 2025) from depreciation normalizes post-COGEN (June 2026), unlocking ₹30-50 Cr annual energy savings. EBITDA margins expand to 24-27% by 2027, supported by operating leverage and premium pricing. Critical success factors: utilization ramp-up (60-70% Year 1) and COGEN timeline adherence. Long-term fundamentals strengthen substantially; near-term execution risk requires monitoring.
Capacity Surge, Margin Recovery Ahead Subam Papers' 71% capacity expansion targets high-margin 80-120 GSM segment, driving 40-50% revenue potential. Near-term margin pressure (-100-200 bps in 2025) from depreciation normalizes post-COGEN (June 2026), unlocking ₹30-50 Cr annual energy savings. EBITDA margins expand to 24-27% by 2027, supported by operating leverage and premium pricing. Critical success factors: utilization ramp-up (60-70% Year 1) and COGEN timeline adherence. Long-term fundamentals strengthen substantially; near-term execution risk requires monitoring.
Capacity Surge, Margin Recovery Ahead Subam Papers' 71% capacity expansion targets high-margin 80-120 GSM segment, driving 40-50% revenue potential. Near-term margin pressure (-100-200 bps in 2025) from depreciation normalizes post-COGEN (June 2026), unlocking ₹30-50 Cr annual energy savings. EBITDA margins expand to 24-27% by 2027, supported by operating leverage and premium pricing. Critical success factors: utilization ramp-up (60-70% Year 1) and COGEN timeline adherence. Long-term fundamentals strengthen substantially; near-term execution risk requires monitoring.
Unlock Premium
Unlock to gain access and review the Impact.
